Table 3.
Heterologous blood donor exposures in first two implant weeks.
| Product | Median | Q1 | Q3 | Mean | Standard Deviation |
|---|---|---|---|---|---|
| PRBC 330 mL/U | 3 | 1 | 8 | 5.2 | 5.9 |
| Platelet Packs | 2 | 2 | 2.5 | 2.1 | .9 |
| FFP 250 mL/U | 4 | 1.5 | 6.2 | 4.6 | 4.1 |
| Cryo 60 mL/U | 0 | 0 | 0 | .2 | .6 |
| Albumin gm/kg | 1.2 | .6 | 2.4 | 1.6 | 1.2 |
| Cell Process mL/kg | 5.1 | 2.8 | 6.5 | 5.0 | 3.3 |
The heterologous blood product donor exposures descriptive statistics for 13 TAH patients during the first 2 weeks of implantation. Platelets are pooled apheresed units about 250 mL. Cryoprecipitate is about 60–70 mL per unit. Albumin is reported as gm/kg administered. Cell process is the volume of autologous red cells per kg transfused on the first implant day. FFP, fresh frozen plasma.